πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 225 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7574340

Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566540

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566465

Artemisinins in the clinical and veterinary management of kinetoplastid infections

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563883

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527802

Vaccine for transcutaneous immunization

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7494980

Antimicrobial peptide and methods of use thereof

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7455994

Methods for producing Marburg virus proteins

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427394

Biodegradable poly(Ξ²-amino esters) and uses thereof

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7419683

Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic ve

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7416878

Immunogenic compositions including rough phenotype Brucella host strains and complementati

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407935

Ricin toxin A-chain fragment for use as a vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7404961

Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family protei

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378257

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378097

Use of penetration enhancers and barrier disruption methods to enhance the immune response

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7375079

Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus ne

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7374931

Vaccine against staphylococcus intoxication

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7351435

Deglycosylated ricin toxin a-chain vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335356

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotei

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332172

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7306806

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7267823

Ebola peptides and immunogenic compositions containing same

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7265215

DNA or RNA encoding a recombinant dengue envelope protein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7259167

Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds havi

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7258863

Heterologous protection induced by immunization with invaplex vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted